BSE Live
Dec 05, 16:01Prev. Close
180.55
Open Price
181.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
180.85
Open Price
181.62
Bid Price (Qty.)
179.85 (143)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 341.71 | 119.80 | -167.52 | 441.03 | 883.58 | |
| Net CashFlow From Operating Activities | 892.30 | 1,004.54 | 483.89 | 766.42 | 597.58 | |
| Net Cash Used In Investing Activities | -477.46 | -434.01 | -1,338.78 | -1,812.10 | -4,479.93 | |
| Net Cash Used From Financing Activities | -440.83 | -422.36 | 817.79 | 794.19 | 3,976.83 | |
| Foreign Exchange Gains / Losses | -10.88 | 17.79 | 5.15 | -2.04 | 4.22 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 76.74 | 11.32 | |
| Net Inc/Dec In Cash And Cash Equivalents | -36.87 | 165.96 | -31.95 | -176.79 | 110.02 | |
| Cash And Cash Equivalents Begin of Year | 219.19 | 53.23 | 85.18 | 261.97 | 151.95 | |
| Cash And Cash Equivalents End Of Year | 182.32 | 219.19 | 53.23 | 85.18 | 261.97 |
12.11.2025
Piramal Pharma Standalone September 2025 Net Sales at Rs 1,127.26 crore, down 12.23% Y-o-Y
06.11.2025
Piramal Pharma Consolidated September 2025 Net Sales at Rs 2,043.72 crore, down 8.83% Y-o-Y
05.11.2025
Piramal Pharma posts Rs 99 crore loss in Q2FY26 weighed down by CDMO business
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y